Table 5

PET/CT findings after induction therapy and subsequent ASCT(s)

No. of patientsPET/CT negativePET/CT positive improvedPET/CT positive unchangedPET/CT positive worsened
  χ2 test significance probability = 0.000
 
  
  (%) (%) (%) (%) 
Baseline 192 24  76  
Postinduction 85 37 14 43 
Post-ASCT 192 65 17 14 
  McNemar significance probability = 0.000
 
  
PET/CT postinduction with respect to baseline  (% of row) (% of row) (% of row) (% of row) 
    Negative  90  10  
    Positive  28 46 19 
PET/CT post-ASCT with respect to baseline  (% of row) (% of row) (% of row) (% of row) 
    Negative  96   
    Positive  56 28 13 
No. of patientsPET/CT negativePET/CT positive improvedPET/CT positive unchangedPET/CT positive worsened
  χ2 test significance probability = 0.000
 
  
  (%) (%) (%) (%) 
Baseline 192 24  76  
Postinduction 85 37 14 43 
Post-ASCT 192 65 17 14 
  McNemar significance probability = 0.000
 
  
PET/CT postinduction with respect to baseline  (% of row) (% of row) (% of row) (% of row) 
    Negative  90  10  
    Positive  28 46 19 
PET/CT post-ASCT with respect to baseline  (% of row) (% of row) (% of row) (% of row) 
    Negative  96   
    Positive  56 28 13 

PET/CT indicates positron emission tomography/computed tomography; and ASCT, autologous stem cell transplantation.

Close Modal

or Create an Account

Close Modal
Close Modal